Abstract

Evidence quality and health technology assessment outcomes in re-appraisals of drugs for rare diseases in Germany

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Algorithms and heuristics of health technology assessments: A retrospective analysis of factors associated with HTA outcomes for new drugs across seven OECD countries
Panos Kanavos ... Arianna Gentilini
Social science & medicine (1982) | VOL. 331
Panos Kanavos, et. al.Panos Kanavos ... Arianna Gentilini
26 Jun 2023
Measures to improve the health situation of patients with rare diseases in Germany. A comparison with the National Action Plan
M Frank ... T.O.F Wagner
Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz | VOL. 57
M Frank, et. al.M Frank ... T.O.F Wagner
11 Sep 2014
Rare diseases in Germany - Developments in the status of medical care.
Katharina Heuing ... Miriam Schlangen
Journal of Health Monitoring | VOL. 8
Katharina Heuing, et. al.Katharina Heuing ... Miriam Schlangen
01 Dec 2023
Diagnostic needs for rare diseases and shared prediagnostic phenomena: Results of a German-wide expert Delphi survey.
Susanne Blöß ... Werner Lechner
PloS one | VOL. 12
Susanne Blöß, et. al.Susanne Blöß ... Werner Lechner
24 Feb 2017
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
Generating utilities for the CS-Base: a novel, generic, and patient-centered health-outcome measure
Xin Zhang ... Paul Fm Krabbe
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Xin Zhang, et. al.Xin Zhang ... Paul Fm Krabbe
06 Jul 2024
Do Behavioral Characteristics Influence the Breast Cancer Diagnosis Delay? Evidence From French Retrospective Data
Christine Le Clainche ... Jean-Christophe Vergnaud
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Christine Le Clainche, et. al.Christine Le Clainche ... Jean-Christophe Vergnaud
06 Jul 2024
Key Issues of Economic Evaluations for Health Technology Assessment in China: A Nationwide Expert Survey
Gordon G Liu ... Huajie Jin
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Gordon G Liu, et. al.Gordon G Liu ... Huajie Jin
06 Jul 2024
Valuation of Multi-Dimensional Health States With a Bolt-On: Is There a Shortcut?
Zhihao Yang ... Nan Luo
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Zhihao Yang, et. al.Zhihao Yang ... Nan Luo
06 Jul 2024
View more papers